ASCVD
Clinical trials for ASCVD explained in plain language.
Never miss a new study
Get alerted when new ASCVD trials appear
Sign up with your email to follow new studies for ASCVD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Specialist Team-Up aims to tame heart risks in diabetic patients
Disease control Not yet recruitingThis study is testing whether a special clinic where heart, kidney, and diabetes doctors work together as a team can help people with type 2 diabetes and heart disease. It will compare this team approach to usual primary care to see if it improves blood pressure and cholesterol c…
Matched conditions: ASCVD
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug trial aims to shrink dangerous artery plaque
Disease control Not yet recruitingThis study is testing whether an experimental drug called ABP-745 can reduce the amount of plaque buildup in the arteries of people with heart disease. Researchers will compare ABP-745 against a placebo in 200 participants over 52 weeks to see if it safely shrinks plaque. The goa…
Matched conditions: ASCVD
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New trial targets hidden genetic driver of heart disease inflammation
Disease control Not yet recruitingThis study is testing whether a drug called canakinumab can reduce dangerous inflammation in the arteries of people who have had a heart attack or stent. It specifically includes people with and without a common age-related genetic change called TET2 CHIP. Researchers will use he…
Matched conditions: ASCVD
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC